Tuberculosis (TB) caused by Mycobacterium tuberculosis remains a global threat to human health. Development of drug resistance and co-infection with HIV has increased the morbidity and mortality caused by TB. Macrophages serve as primary defense against microbial infections, including TB. Upon recognition and uptake of mycobacteria, macrophages initiate a series of events designed to lead to generation of effective immune responses and clearance of infection. However, pathogenic mycobacteria utilize multiple mechanisms for manipulating macrophage responses to protect itself from being killed and to survive within these cells that are designed to kill them. The outcomes of mycobacterial infection are determined by several host-and pathogen-related factors. Significant advancements in understanding mycobacterial pathogenesis have been made in recent years. In this review, some of the important factors/mechanisms regulating mycobacterial survival inside macrophages are discussed.
Tuberculosis causes millions of human morbidities every year and is the ninth leading cause of human death worldwide. TB is also the leading cause of human mortality caused by a single infectious agent. It caused about 10.4 million new infections and more than 1.7 million deaths (including 0.37 million deaths attributable to co-infection with HIV) in 2016. TB is a global health concern, especially in developing countries such as India and China. TB is caused by Mycobacterium tuberculosis and other members of the Mtb complex (group of species including Mtb, M. canettii, M. africanum, M. microti, M. bovis, M. caprae and M. pinnipedii) (1) . Emergence and spread of multi-drug resistant and extensively drug resistant strains of Mtb have further raised the death toll and complicated the treatment and management of TB (1) (2) (3) (4) . TB was declared a global health emergency by the World Health Organization in April 1993 (5) . This declaration laid the foundations for intensive efforts to treat and control the spread of TB through supervised medication, such as implementation of the directly observed therapy short course strategy (1, 6) . Despite these initiatives having some success, new drugs are still needed to control this serious disease because currently available drugs require long-term treatment, have considerable higher toxicity and resistance to them continues to emerge (1) (2) (3) (4) 6) . TB infections occurs through inhalation of the pathogen in aerosol form generated by an infected individual coughing, sneezing, singing, or even simply talking; that is, TB is highly contagious. The innate immune defense system serves as the first line of defense against microbial pathogens infecting multicellular organisms. Macrophages, the most important cells of vertebrate immune systems, are critical for both the innate and adaptive arms of immune response. These cells are phagocytic, recognizing and engulfing microbial pathogens into vacuoles called phagosomes. Phagosomes then fuse with lysosomes to acquire lysosomal hydrolytic enzymes in a process called phagosomal maturation, resulting in killing/degradation of the internalized material. Once in the lungs, mycobacteria are internalized through receptor-mediated phagocytosis by alveolar macrophages (macrophages residing in the lungs), within which they survive, and replicate, creating infective foci in the alveolar walls (7, 8) . Phagocytosis of pathogens by macrophages results in activation of local inflammatory responses, leading to recruitment of mononuclear cells from neighboring blood cells and eventually formation of a granuloma, a structure characterized by central infected macrophages surrounded by foamy giant cells with lymphocytes around the periphery (Fig. 1 ). Mycobacteria may remain viable within these structures for decades, posing a lifelong threat of development of active disease (9, 10) . In individuals with appropriate immune responses, mycobacteria are killed by macrophages whereas in individuals with weaker immunity, macrophages fail to kill and eliminate mycobacteria, leading to latent or active TB (11, 12) . Intracellular pathogens adopt various strategies to avoid the primary defense mounted by macrophages. Many intracellular pathogens that escape phagocytosis by macrophages are taken up by more weakly bactericidal cells. Other microbial pathogens are equipped to survive the otherwise hostile environment within lysosomes. Pathogenic mycobacteria have developed mechanisms to avoid phagocytosis by macrophages (13) , resist macrophage antimicrobial responses (14) , inhibit phagosomal maturation and adapt to the lysosomal environment (15) . Macrophages respond to mycobacterial infection by activating a series of defense strategies; however, this pathogen has evolved several tricks for escaping or neutralizing the host's immune defense strategies. Thus, pathogenic mycobacteria can survive and multiply within the otherwise hostile environment inside macrophages for prolonged periods of time (16) (17) (18) (19) . Whether an individual infected with Mtb develops active TB or not is determined by the efficacy with which their macrophages eliminate intracellular Mtb. Several factors of both host and pathogen origin regulate this process and ultimately determine the final outcomes of infections (12, 18) . Here, we discuss some of the important factors that determine the intracellular fate of mycobacteria within macrophages.
MACROPHAGES INTERNALIZE MYCOBACTERIA THROUGH RECEPTOR-MEDIATED PHAGOCYTOSIS
Mycobacteria are facultative intracellular pathogens and have developed several mechanisms for entering macrophages. These bacilli are actively internalized by macrophages through receptor-mediated phagocytosis, a process that requires recognition and binding of ligand molecules exposed on the mycobacterial surface by specific receptor molecules present on macrophage cell surfaces. Mycobacteria may be recognized by several different types of receptors. CRs types 1, 3 and 4 can bind mycobacteria coated with complement components C2b, C4b and C3bi (opsonins). Mtb can also activate alternate pathways of complement activation to produce complement components that facilitate mycobacterial opsonization and uptake by macrophages. CR3 can also bind non-opsonized Mtb. Expression of CR3 decreases whereas that of CR4 increases during maturation of monocytes into macrophages (20, 21) . Cholesterol (a membrane steroid) accumulation in the plasma membrane at the site of mycobacterial entry is essential for phagocytosis of mycobacteria by CR3 receptors and association of host protein coronin 1 (a member of tryptophan-aspartate containing coat protein family) with phagosomes containing mycobacteria. Association of coronin-1 with the phagosomal membrane leads to arrest of phagosomal maturation (22) .
The MR, a C-type lectin, is expressed on the surfaces of mature macrophages but not monocytes. Man-LAM, an abundant lipid present on the surface of Mtb, serves as a ligand for MR. Man-LAM-MR binding depends on terminal mannose residues and mediates phagocytosis of Mtb by macrophages (23) . Clinical isolates of Mtb with defects in LAM structure that result in altered phagocytosis by macrophages have also been identified (24) . Phagocytosis of Mtb through MR leads to inhibition of phagosomal maturation and MR blockade during phagocytosis of virulent Mtb results in reversal of phagosomal maturation inhibition in human macrophages (25) . Interestingly, MRs can bind the virulent Mtb Erdman and H37Rv strains, but not the avirulent Mtb H37Ra strain (26) . These findings indicate the ability of pathogenic mycobacteria to engage different macrophage receptors to induce different endocytic pathways that lead to enhancement of intracellular survival.
Mincle, another member of the C-type lectin receptor family, helps in sensing Mtb infection through macrophages recognizing and binding it (27) (28) (29) . TDM (also known as mycobacterial cord factor), a wellknown glycolipid abundantly found in the cell walls of pathogenic mycobacteria, serves as a ligand for Mincle (29, 30) . TDM delays maturation of mycobacterial phagosomes (31) in a Mincle dependent manner (32) , thereby contributing to the virulence of mycobacteria. Purified TDM activates macrophages and promotes granuloma formation in mice (30) . Mincle is required for macrophages' pro-inflammatory responses during mycobacterial infection: secretion of inflammatory cytokines has been shown to be reduced in Mincle-deficient macrophages (28, 29, 32) . In vivo studies using Mincle À/À mice showed efficient macrophages effector and Th responses in mutant mice similar to that of wild type mice. Equal bacterial loads in the lungs of the infected mice were also reported, suggesting that Mincle is not essential for protection against Mtb in mice and that its function may be compensated by other receptors in vivo (33) . Contrary to these observations, another study by Lee et al. reported higher bacterial burden in the lungs of Mincle À/À mice (34) . Differences in infection outcomes may be attributable to differences in the structure and relative abundance of TDM in the different strains of Mtb used in these studies (33, 34) .
Antibodies generated in response to infection may also bind to and coat the surfaces of mycobacteria and act as opsonins (35) . Immunoglobulin fragments carrying the constant region of the heavy chain (Fc) region of these antibodies are recognized by Fc receptors on phagocytic cells, resulting in phagocytosis of antibodyopsonized mycobacteria. Fc gamma receptor-mediated uptake of virulent Mtb results in delivery of mycobacterial phagosomes to lysosomes; however, this does not alter the intracellular survival of mycobacteria (36) .
Surfactant protein A is the predominant protein in the surfactant found in pulmonary alveoli. Sp-A is a member of the collectin family of proteins and at least three types of receptors specific to this protein are present on macrophages. Sp-A enhances mycobacterial binding and uptake by macrophages by acting as an opsonin and/or modulating the activity of macrophage receptors directly involved in the process, such as CR, MR and Fc receptors (21) . Sp-A has also been shown to upregulate MR, thereby promoting bacterial phagocytosis, whereas Sp-D inhibits MR-dependent uptake of mycobacteria by masking mycobacterial Man-LAM (37) .
Macrophage scavenger receptors (which bind polyanionic macromolecules) and CD14 (which binds LAM) have also been reported to mediate mycobacterial uptake; however, it is unclear whether these receptors are capable of mediating phagocytosis without the cooperation of other membrane proteins (38, 39) . Scavenger receptors have also been shown to be involved in regulating phagocytosis during autophagy (40) .
Distinct routes for mycobacterial entry may direct activation of distinct signaling pathways and cytokine secretion by infected macrophages. These responses may result in distinct outcomes of Mtb infection. Usage of several receptors for phagocytosis of mycobacteria suggests that different receptors may be useful during different phases of infection. During the initial stages, receptors capable of binding mycobacteria directly (such as MR and CR3) may mediate phagocytosis. In later phases of infection, when antibodies against mycobacterial components are present and complements component are being produced as result of complement activation, receptors that require these molecules (such as Fc receptors and CR1, CR3 and CR4) may participate in binding and internalization of pathogens.
MYCOBACTERIA PERSIST IN MACROPHAGES BY INHIBITING PHAGOSOME-LYSOSOME FUSION
Arrest of phagosomal maturation is the hall mark of mycobacterial infection (41) . Many molecules of both host and pathogen origin are associated with this process. Members of the coronin protein family have been shown to be involved in actin-cytoskeleton remodeling, phagocytosis, cell division and polarity, and vesicular trafficking from the endoplasmic reticulum to the Golgi. In one study, coronin-1 was shown to be essential for arrest of maturation of phagosomes containing live pathogenic mycobacteria. In mouse macrophages infected with live pathogenic mycobacteria, coronin-1 constantly associated with phagosomes. In the case of macrophages infected with dead mycobacteria, coronin-1 rapidly dissociated from phagosomes, resulting in fusion of the phagosomes with lysosomes and subsequent degradation of engulfed mycobacteria (42) . In a follow up study, coronin-1 was shown to be required for Ca 2þ -dependent activation of calcineurin (a calcium dependent phosphatase), which is essential for inhibition phagosomal maturation (43) .
Biosynthesis of PI3P, a membrane-trafficking regulatory phosphoinositide, is required for phagolysosome biogenesis (44) . Man-LAM from Mtb, an analogue of PI3P, reportedly blocks phagosome maturation (45, 46) . Man-LAM also inhibits calcium efflux following phagocytosis, which is required to increase cytosolic Ca 2þ concentrations in the macrophages (44) , which in turn results in inhibition of calmodulin and CaM-dependent protein kinase II (47) and accumulation of PI3P on the phagosomal membranes. In contrast, PI-LAM, which is present in the cell walls of non-pathogenic mycobacteria such as MS, promotes fusion of phagosomes to early endosomes (25, 44) .
Of interest, inhibition of phagosomal maturation by pathogenic mycobacteria does not affect the processing and presentation of mycobacterial antigens by macrophages or DCs (48) . Mycobacterial proteins are also involved in regulating phagosomal maturation and intracellular survival of mycobacteria. Mycobacterial PknG has been shown to promote intracellular survival of mycobacteria by inhibiting phagosomal maturation. Disruption of pKnG results in the lysosomal delivery of Mycobacterium bovis BCG and subsequent killing by macrophages. PknG is actively secreted by mycobacteria into phagosomes and the cytosol of infected macrophages. MS, a non-pathogenic species of mycobacteria, is unable to prevent phagosomal maturation. Expression of PKnG into MS reportedly inhibits lysosomal delivery and increases survival in macrophages (49) . Mycobacterial PknG shows the closest homology to mammalian PKC-a. Prior treatment of BCG with chelerythrine, an inhibitor of PKC-a, results in the lysosomal delivery of mycobacteria and subsequent killing by macrophages, suggesting that PKC-alike kinase activity is involved in blocking maturation (50) . Phagosomes containing PknG-expressing mycobacteria retain coronin-1 and do not acquire lysosomal associated membrane protein-1, a lysosomal marker (49) . Mammalian PKC-a has been shown to be associated with phagosomal membranes and to regulate the association of p57 (the human homolog of coronin-1) and lysosomal associated membrane protein-1 on phagosomal membrane (51) . Indeed, in one of our previous studies, we showed that pathogenic mycobacteria expressing PknG can downregulate macrophage PKC-a during infection and that this downregulation results in increased survival of mycobacteria within macrophages (13, 52) . Interestingly, PknG does not phosphorylate/dephosphorylate PKC-a but induces degradation of PKC-a by direct interaction probably attributable to proteolytic activity in PknG (13) . Incubation of purified PknG results in selfcleavage of the protein, suggesting it has protease-like activity (13, 53) . These observations are also supported by another group's studies in which it was shown that autophosphorylation of PknG is non-essential for regulating its kinase activity but is crucial for PknG's ability to inhibit phagosomal maturation in mycobacteria-infected macrophages (54) . Overexpression of PknG in MS also inhibits phagocytosis by human macrophages (13) , suggesting that PknG has more functions in mycobacteria than inhibition of phagosomal maturation. Interestingly, some other studies have reported natural expression of PknG in MS (14, 55, 56) . This poses a question: why does the intracellular behavior of recombinant MS expressing Mtb PknG differ from that of wild type counterparts, as observed in earlier studies (13, 49, 54) ? One possibility is that MS PknG or Mtb PknG have different activities/ substrate specificities/regulatory mechanisms, another is that their expression inside host macrophages is regulated differently. This remains unknown and need to be addressed to further clarify the role of PknG in mycobacterial biology and infection. A recent study found that pathogenic mycobacteria can also survive within lysosomes. BCG mutants with disrupted pknG were also found to survive and multiply within lysosomes during later phases of infection (57) .
CELLS OTHER THAN MACROPHAGES ARE ALSO IMPORTANT IN MOUNTING IMMUNE RESPONSES AGAINST MYCOBACTERIAL INFECTION
Dendritic cells are regarded as professional antigenpresenting cells and serve crucial roles in mounting immune responses against bacterial pathogens. Invading pathogens in the peripheral tissues are recognized and captured by immature DCs, which process them into peptide fragments. The DCs then migrate to lymphoid tissues where they undergo maturation and present microbial antigens on their surfaces in combination with MHCs. Antigen-MHC complexes are then recognized by naive T cells. Binding of antigen-MHC complex with T-cell receptors results in initiation of a series of events that eventually leads to the activation and differentiation of naive T cells (58) (59) (60) (61) . Naive T cells can either differentiate into Th 1 or Th 2 cells, which of these being determined by the type of antigen recognized (62, 63) . Recognition of antigens derived from pathogenic mycobacteria drives differentiation of naive T cells into Th 1 cells, which secrete IFN-g (64, 65), whereas Th 2 cells produce IL-4 (66). IFN-g activates macrophages, which is critical for elimination of intracellular pathogens such as Mtb (67, 68) . Th1 responses provide protection against mycobacterial infection whereas Th2 responses do not and accordingly correlate with disease progression (69) . Following the apoptotic death of infected macrophages, neutrophils are attracted and recruited to the resultant sites of release of mycobacteria into the extracellular space. These cells take up such mycobacteria and rapidly kill them in an ROI-dependent manner. Neutrophils are very important in containing mycobacteria released from apoptotic/necrotic macrophages (70) (71) (72) . Virulent strains of Mtb have also been shown to induce ROI-mediated necrosis in neutrophils as an escape mechanism to avoid being killing by them (73) .
CYTOKINES REGULATE IMMUNE RESPONSES AGAINST MYCOBACTERIAL INFECTIONS
Encounters with Mtb activates phagocytic cells, which respond by secreting cytokines, which in turn leads to further activation and cytokine production in a complex process of auto-and cross-regulation. The cytokines thus produced play a critical part in regulating the inflammatory response to, and outcome of, Mtb infections (74) . IL-12 is secreted by macrophages and DCs following phagocytosis of bacterial pathogens and plays a crucial role in the development of Th1 cells from naive T cells (75, 76) . The Th1 cells then secrete IFN-g, resulting in activation of macrophage's bactericidal responses (67, 77) . IFN-g may increase antigen presentation, leading to recruitment of CD4 þ T lymphocytes and/or cytotoxic T lymphocytes that participate in killing of Mtb (78) . The protective roles of IFN-g in TB are well established (79) (80) (81) . In humans, defects in genes for IFN-g or its receptor have been shown to confer increased susceptibility to mycobacterial infections (68, 82) . IFN-g knockout mice also show very high susceptibility to Mtb infections (79, 80) . Mtb has also been shown to use several molecular pathways/mechanisms to limit macrophage activation by IFN-g (83) (84) (85) (86) (87) (88) . One important such mechanism is inhibition of IL-12 production by infected macrophages. Macrophages infected with pathogenic mycobacteria such as Mtb have been shown to produce less IL-12 than macrophages infected with non-pathogenic mycobacteria (89) . IL-12 is a crucial cytokine for anti-mycobacterial immune responses. IL-12 deficient mice have been shown to be more susceptible to Mtb infection than wild type mice (90, 91) . Additionally, individuals with mutations in the genes for IL-12 or IL-12 receptor have been shown to have greater susceptibility to mycobacterial infections (92, 93) .
IL-1b is induced in macrophages infected with Mtb and IL-1b knockout mice have been shown to be more susceptible to this infection, suggesting that this cytokine plays important roles in anti-mycobacterial immune defenses (94) . The mechanism for protective effects of IL-1b in Mtb infection is not understood clearly; however, these protective effects may be mediated by IL-1b's synergistic activity in inducing anti-mycobacterial host responses such as formation of ROI and RNI (95, 96) . Synthesis of IL-1b requires activation of inflammasomes and caspase-1. Mtb can inhibit this activation pathway by inducing formation of IFN-b, thus contributing to the escape of bacilli from immune responses (97) .
The role of TNF-a, which is secreted by Mtb infected macrophages, DCs and T cells, in control of mycobacterial infection is complex. TNF-a may have multiple roles in both immune responses and pathologies in TB. It is required for the control of Mtb infection via inducing expression of nitric oxide synthase 2 (98-100). TNF-a is important in walling off infection and inducing granuloma formation, thus hindering dissemination (101, 102) . Mtb infection in TNF-a-or 55 kDa TNF receptor-deficient mice reportedly results in significantly higher bacillary loads and more rapid deaths than in control mice (103) . IL-10 is produced by macrophages following phagocytosis of Mtb (104) and/ or binding of mycobacterial LAM to macrophage MR (105) . IL-10 may directly inhibit CD4 þ T cell responses and/or by inhibiting antigen presentation by cells infected with mycobacteria (106) . IL-10 also induces down regulation IFN-g, TNF-a, and IL-12 production, thereby contributing to suppression of pro-inflammatory responses (107, 108) . Genetic studies on mice have confirmed an important role for this cytokine in promoting bacillary loads during infection (109, 110) . Tumor growth factor-b is another cytokine that is produced by human monocytes and DCs after stimulation with Mtb (111) or LAM (105) . This cytokine is present in the granulomatous lesions of individuals with TB and counteracts protective immunity against TB by exerting anti-inflammatory effects such as deactivation of macrophage production of ROI and RNI (112) , inhibition of T cell proliferation (106), interference with NK and cytotoxic T lymphocyte function and downregulation of IFN-g, TNF-a and IL-1 release (113). IL-4 cytokine is secreted by a Th 2 subset of CD4 þ T lymphocytes (114, 115) . IL-4-secreting T cells are reportedly present in persons with active TB and may be isolated (116). Th 2 responses, which are characterized by secretion of IL-4, limit Th 1 responses (117, 118) . Because it is unable to inhibit Th 1 responses, IL-4 may skew away the protective immunity in response to mycobacterial infection. IL-4 has also been reported to influence granuloma formation during Mtb infection (9, 119) . Interestingly, anti-TB treatment has been shown to be associated with IL-4 concentrations, which decrease in the plasma of patients undergoing anti-TB treatment (120) . IL-22 enhances anti-mycobacterial activity in macrophages by activating phagolysosomal maturation (121) . IL-17 is another important cytokine that is required to induce protective T cell-mediated immune responses against Mtb (122).
PROTEIN KINASES REGULATE MYCOBACTERIAL ADAPTATION AND SURVIVAL INSIDE HOST CELLS
Protein kinases are enzymes that add phosphate group to Ser, Thr or tyrosine residues of proteins and thereby regulate the activity of target proteins. Protein phosphorylation is a major signal transduction mechanism in both prokaryotic and eukaryotic cells, regulating their metabolism in response to external environmental signals. In bacteria, signal transduction is mediated by two-component regulatory systems as well as specific protein kinases and protein phosphatases. The Mtb genome encodes for eleven eukaryotic-like S/TPKs. The genes of all these S/TPKs have been shown to encode functional kinases and many of them have been found to play roles in regulating various cellular events, such as chemotaxis, environmental adaptation, differentiation, cell shape, cell division and virulence. All these kinases are mainly localized in the plasma membranes and cell walls of Mtb, the exception being PknG, which predominantly localizes in cytoplasm (123) . During the infection process cross-talk between host-and bacterium-derived signals lead to reprogramming of cellular events in both organisms. Protein kinases, being key components of the signal transduction pathways of Mtb, play key roles in the signaling network that allows Mtb to survive in the hostile microenvironment within the host.
PknA and PknB are encoded in the same operon as genes involved in cell wall synthesis and have been reported to regulate cell morphology and division in response to environmental signals through regulation of specific pathways involved in cell wall peptidoglycan synthesis (124) (125) (126) . PknA-mediated control of cell division is FtsZ-dependent and may be regulated by mycobacterial Ser/Thr phosphatase (Rv0018c) (126) (127) (128) . Both pknA-and pknB-defective Mtb mutants fail to survive in mice, suggesting they play an essential role in survival of this pathogen during infection (129, 130) . PknD is autophosphorylated on 11 residues, binds proteins containing FHAs, and contains a b-propeller motif that probably functions as an anchoring sensor domain. PknD has been shown to phosphorylate both Rv0156c and MmpL7, a transporter protein that is essential for virulence, presumably because it transports phthiocerol dimycocerosate to the cell wall (131, 132) . PknD phosphorylates Rv0516c at Thr 2 and this phosphorylation results in inhibition of Rv0516c binding to homologous anti-anti-Sigma factor Rv2638 (132) . Rv0516c regulates expression of sigma factor F in Mtb in response to stress signals (133); thus, it may regulate expression of a specific set of genes that are required for Mtb adaptation to environments encountered during infection. In one study, Mtb with defective pknD reportedly had impaired invasion and survival in brain microvascular endothelial cells, but not in activated J774 cells, epithelial A549 cells or umbilical vein endothelia, suggesting that PknD is a crucial factor in TB of the central nervous system (134) .
Apoptosis play an important role in eliminating intracellular infections. PknE serve as a virulence factor because it supports the persistence of Mtb in human macrophages by inhibiting TNF-a-mediated apoptosis through elimination of RNI (135) . PknE is also involved in regulating resistance to nitrosative stress (136) , one of the most important stresses faced by pathogens upon entering macrophages. These findings suggest PknE plays a role in moderating host responses toward favoring survival of pathogens. PknF has been implicated directly or indirectly in regulation of glucose transport, cell growth and septum formation in Mtb (137) . An ABC transporter (Rv1747) containing a FHA domain interacts with PknF in a kinase-dependent manner; it has been suggested that this interaction is required for sustaining growth of Mtb during infection in mice. However, PknF-mutated Mtb grow normally in macrophages, which might be attributable to compensatory PknF-mediated phosphorylation of Rv1747 by some other Mtb kinases (138) . In one study, PknF was shown to phosphorylate b-ketoacyl-acyl carrier protein synthase III at Thr 45 , leading to inhibition of its enzymatic activity, which in turn suggests its possible role in regulating mycolic acid biosynthesis in Mtb (139) .
PknG is essential for establishment of intracellular infection because of its ability to block phagosomelysosomal fusion following mycobacterial uptake by macrophages. PknG is secreted into the host macrophage cytosol, where it may phosphorylate host protein-(s) and interfere with host signal transduction processes involved in host trafficking pathways, leading to maturation arrest of mycobacterial phagosomes (49) . pknG gene is part of a putative operon containing glnH, a gene encoding for a protein involved in glutamine uptake. The role of PknG in regulation of glutamate metabolism in mycobacteria is debatable. Cowley et al. have shown that mutation of pknG results in accumulation of cellular glutamate/glutamine in Mtb (53) . In contrast, deletion of pknG does not affect cellular levels or uptake of glutamine in BCG. pknG deletion in BCG also does not alter transcription of the other genes in the operon, including glnH (140). In agreement with Cowley et al., PknG has been shown to regulate glutamate metabolism in both Mtb and MS by phosphorylating GarA at Thr 21 . Unphosphorylated GarA inhibits aketoglutarate decarboxylase in the TCA cycle. GarA has also been shown to bind and modulate the activity of a large NAD þ -specific glutamate dehydrogenase with low affinity for glutamate. Thus, defects in glutamate metabolism caused by pknG deletion may be attributable to the effects of unphosphorylated GarA on the activities of these two enzymes, which may also contribute to attenuation of virulence (55, 141) . PknG-mediated phosphorylation of GarA, which is regulated by nutrient availability, has been shown to be essential for survival of Mtb in macrophages and mice, which indicates the importance of metabolic adaptation in Mtb during infection in promoting survival of this pathogen (142) .
A recent study using a proteome microarray showed that PknG plays a role in regulating cell wall integrity via regulating biosynthesis of peptidoglycan, a key component of mycobacterial cell walls (143) . PknG also reportedly promotes intrinsic resistance to antibiotics (56) , stress response and biofilm formation (14) . It appears that PknG regulates several processes during infection in macrophages and that inhibition of PknG may be a good strategy for controlling mycobacterial replication inside host macrophages. Because PknG is secreted by live mycobacteria into the cytosol of infected macrophages; drug penetration into the mycobacteria is not required to target it. This makes PknG a highly attractive target for anti-mycobacterial drugs, especially considering that mycobacteria possess an extremely complex, thick and impermeable cell envelope.
It has recently been reported that Mtb and BCG initially resist lysosomal transfer in vivo but after prolonged infection these bacilli are transferred to lysosomes, yet continue to proliferate. pknG mutant BCG, which is unable to resist lysosomal transfer, survives and proliferates in vivo (57) . During infection in mice, pknG knock out Mtb show only partial defects in replication, whereas GarA-deficient Mtb are completely unable to replicate (141, 144) . These findings indicate that some functions of PknG may be dispensable and compensated for by other kinases in vivo. Another recent study has proposed that PknG plays a role in regulating the cellular metabolism required for mycobacterial adaptation in stress conditions faced during hypoxia. Thus PknG contributes towards mycobacterial persistence by stabilizing the granulomas (145) . PknG also increases intrinsic acid resistance and supports mycobacterial survival in acidic environments (146) . Taken together, these findings indicate that PknG-mediated enhanced intracellular survival of mycobacteria may depend on its ability to regulate the metabolism required to protect mycobacteria from the various stresses they face inside macrophages. PknG may also be the central regulator of stress response in mycobacteria. Studies to further analyze the role of PknG in regulating intracellular survival beyond its ability to inhibit phagosomal maturation are warranted.
The multiple roles of PknG in mycobacteria are summarized in Figure 2 . The major acid resistance system in bacteria is glutamate decarboxylation (147) (148) (149) (150) . To the best of our knowledge, the role of glutamate decarboxylase in mycobacterial resistance to acidic environments has not yet been elucidated. It is not known whether there is a functional glutamate decarboxylase dependent acid resistance system in mycobacteria, nor whether it is regulated by PknG. PknH, a transmembrane protein, is exclusively expressed in mycobacteria that belong to the Mtb complex. Mtb exposure to low pH and heat shock decreases pknH transcription, indicating it's ability to regulate cellular events to promote bacterial adaptation to environmental changes (151) . PknH interacts with EmbR in an FHA-dependent manner, resulting in phosphorylation of EmbR by PknH. EmbR is a transcriptional regulator of embCAB operon encoding arabinosyl transferases in Mtb. Phosphorylation of EmbR by PknH enhances its DNA binding activity towards promoter regions of embCAB genes (152) . In vivo studies involving expression of PknH in MS have established it's positive regulatory effect on transcription of the embCAB operon via phosphorylation of EmbR. Interestingly, increased transcription of embC, which catalyzes arabinosylation of LM to LAM, results in a high LAM/LM ratio, which in turn is a crucial virulence factor in mycobacteria (153) . Papavinasasundaram et al. have shown that DpknH Mtb mutants survive and replicate more vigorously in mouse organs than do their parental or pknH-complemented strains (154) . In contrast, in vitro and intracellular growth is not changed in DpknH mutants. Further, DpknH mutants replicate less vigorously in a non-stimulated human macrophage cell line than do the wild-type and complemented strains. These results suggest that PknH regulates intracellular replication of Mtb through a signaling pathway that requires activation by external stimuli. pknH mutants of Mtb are more resistant to nitric oxide in vitro, indicating that PknH plays a role in sensing free radicals produced by activated host cells, which may contribute to their survival (154) . In fact, PknH has also been shown to phosphorylate DosR, which in turns regulates transcription of hypoxiaand NO-inducible dormancy (DosR) regulon (155) . PknH also regulates growth and survival of Mtb by phosphorylating InhA, a key enzyme of the fatty-acid synthase II system, thereby regulating mycolic acid biosynthesis (156) .
PknI of Mtb has an unusual amino acid composition in its catalytic loop and shows auto-and transphosphorylation activity at the Ser and Thr residues (157) . PknI localizes to the cytosol of Mtb and its expression decreases during infection, suggesting it plays a role in regulating intracellular adaptation (158) . Mtb mutant lacking pknI grows better in acidic pH and with limited oxygen availability. Deletion of pknI results in increased growth of Mtb mutant within macrophages during in vitro infection and a hypervirulence phenotype in mice with severe combined immunodeficiency. It has been proposed that internal signals used to activate PknI are probably host-associated signals such as low pH associated with limited oxygen availability and that PknI plays a role in sensing the host macrophage's environment and translating it to slow the growth of Mtb within the host (159) .
PknK is the largest STPK in Mtb and is implicated in both in vitro and in vivo growth of mycobacteria. Expression of pknK in BCG decreases in the stationary phase whereas it increases during infection in macrophages (160) . PknK deletion from Mtb results in altered colony morphology and increased resistance to acidic pH, hypoxia, and oxidative and stationary phase stresses in vitro. Additionally, PknK mutant Mtb displays an increased replication rate both in vitro and in immunocompetent mice (161) . PknK-mediated growth control involves regulation of transcription and translation (162) . PknK may regulate expression of mymA operon genes through phosphorylation of VirS, a regulator of the mono-oxygenase operon (163) .
PknJ and PknL are the least studied Mtb kinases. Glycolytic enzyme pyruvate kinase A is phosphorylated by PknJ, suggesting its role in regulating metabolism. It is possible that PknJ regulates aerobic and anaerobic metabolism during infection (164) . PknL phosphorylate Rv2175c, a DNA binding protein, indicating it's possible role in regulating gene expression patterns (165) .
The functions of mycobacterial STPKs are summarized in Table 1 .
MACROPHAGE ACTIVATION ENHANCES ANTI-MYCOBACTERIAL RESPONSES AND IS LIMITED BY PATHOGENIC MYCOBACTERIA
One of the most important molecules that promotes macrophage-activation against pathogenic mycobacteria is IFN-g, which is secreted by activated T cells and NK cells during infection (79, 80, 166) .
Activated macrophages engage in a broad range of functions, including immunity against intracellular or extracellular infections, cellular proliferation, inflammation, tissue damage and repair. It has been proposed that activated macrophages constitute two broad subtypes based on both these functions and the pattern of cytokines secreted by them; namely, classically activated or M1 and alternatively activated or M2 macrophages (167) .
Binding of IFN-g to its receptor signals activation and differentiation of macrophages into M1 phenotypes. These cells display enhanced secretion of IL-12, TNF-a, IL-15, IL-23 and IL-1b; increased production of reactive oxygen intermediates, increased antigen presentation, and microbicidal and cytotoxic properties (168) . Some other stimuli, such as LPS, TNF-a and granulocytemacrophage colony stimulating factor, also promote activation and differentiation of macrophages into the M1 subtype (167, 169) .
Differentiation of macrophages into M2 subtypes is driven by IL-10, IL-4, IL-13, ligands of TLRs, immune complexes and some glucocorticoids. M2 macrophages control inflammation and favor Th2 type immune responses (170), which are not protective against Mtb infections. Increased production and secretion of IL-10 and very low concentrations of IL-12 are the main characteristics of these macrophages subtypes (171) .
It has also been reported that macrophage polarization influences microbicidal activity and cytokine production during formation of granulomas, suggesting they have important roles in Mtb infection (172) (173) (174) . Their ability to promote differentiation of M1 macrophages suggests that IFN-g signaling is crucial for containment of Mtb infections.
IFN-g signaling modulates several other cellular processes that occur during infection, such as antigen presentation (78), leukocyte-endothelium cell interactions (175), cell growth, apoptosis (176) and phagosomal maturation (177) . Genetic defects in components of IFN-g signaling confer very strong susceptibility to mycobacterial infections in both mice and humans (68, 79) . Recognition and binding of mycobacteria by TLRs on macrophages surfaces also transmit signals that lead to macrophages activation (178, 179) . Engagement of TLRs by mycobacteria leads to activation of MAPK signaling pathways. Activation of MAPKs results in activation of the signaling cascades required to activate transcription factors, leading to synthesis of TNF-a, chemokines and other immune inflammatory mediators as well as a burst of nitric oxide production. Consequently, these effector molecules regulate macrophage's antimicrobial and inflammatory immune responses, including rapid phagosome-lysosome fusion (180, 181) . These pathways are likely to be modulated by macrophage-mycobacteria interactions that favor mycobacterial survival inside macrophages. Pathogenic mycobacteria have been shown to inhibit MAPK activation during macrophage infections (182) . þ Tcells leads to activation, proliferation and the subsequent release of various cytokines, which ultimately leads to amplification of macrophage responses and recruitment of pro-inflammatory leukocytes. Antigen processing, transportation and final presentation of antigenic peptides in combination with MHC II molecules is a complex process. Activation of macrophages by IFN-g leads to increased expression of MHC class II molecules, Probably involved in regulating gene expression (165) increased antigen presentation and subsequent activation of antigen specific CD4 þ T-cells (79, 80, 186) . Mtb has developed several mechanisms for limiting macrophage activation by IFN-g (84, 87, 88, 187) . Infection of macrophages with Mtb results in reduced expression of MHC class II as a result of TLR2-dependent inhibition of MHC class II transactivator (regulator of MHC II transcription in APCs) expression, which leads to poor antigen presentation (86) . Mtb can also inhibit antigen presentation in macrophages via inhibiting expression of several other genes involved in antigen processing and presentation (87) . This pathogen can also inhibit antigen presentation in DCs without inhibiting MHC class II expression (188) . Binding of LAM of Mtb on DC-SIGN receptors inhibits DC maturation (189) . A recent study on mice reported more efficient activation of Ag85B specific CD4
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þ T-cell response by interaction of these cells with macrophages infected with BCG than by interaction of T cells with macrophages infected with Mtb. Differences in T cell responses have been shown to be attributable to reduced antigen presentation by Mtbinfected macrophages (190) . The notion that IFN-g may overcome the inhibitory effect of mycobacterial infection on macrophage activation has also been challenged by the findings of a recent study by Thirunavukkarasu et al. Pre-treatment of macrophages with IFN-g selectively overcomes the inhibitory effect of mycobacterial antigens, non-pathogenic MS and dead pathogenic mycobacteria on macrophage effector responses whereas the same pretreatment does not overcome an inhibitory effect on macrophage effector responses (including MHC II expression and nitrous oxide production) to live pathogenic mycobacteria (191) .
MAN-LAM INTERFERES WITH HOST SIGNALING AND PROMOTES SURVIVAL OF PATHOGENIC MYCOBACTERIA
Mycobacteria have unique lipid-rich cell walls composed of mycolyl-arabinogalactan-peptidoglycan complex along with LM and LAMs. The structure, biosynthesis and role of mycobacterial cell wall lipids in hostpathogen interaction have been nicely reviewed by Mishra et al. (192) . These lipids are critical to mycobacterial growth, cell viability (193, 194) and mycobacterial interaction with host cells. Man-LAM, which are characterized by the presence of mannosyl caps, are found in slow-growing mycobacteria such as Mtb, M. leprae and BCG (195) , whereas PI-LAM have phosphoinositide caps and are present in fast-growing mycobacteria such as MS (196) . Man-LAM inhibits phagosomal maturation (45) , probably via inhibiting calcium efflux associated with phagocytosis (44) in a MR-dependent manner (25) . Phagosome maturation arrest by Man-LAM requires incorporation of Man-LAM into the membrane lipid rafts (197) . It has also been suggested that Man-LAM activates macrophage tyrosine phosphatase SHP-1, which impairs Ca 2þ signaling (89) . In contrast, despite being incorporated into endomembranes (to a lesser extent than Man-LAM), PI-LAM from avirulent MS does not block phagosomal maturation or the increase in cytosolic Ca 2þ following phagocytosis (25, 44, 197) . DC-SIGN receptors on DCs specifically recognize pathogenic mycobacteria that belong to the tuberculosis complex and mediate the interaction of mycobacteria with DCs (198, 199) . Binding of purified Man-LAM, but not of arabinosecapped lipoarabinomannan, to DC-SIGN on immature DCs blocks both LPS-and BCG-induced maturation of DCs by reducing expression of both Class II MHC and costimulatory (CD80, CD83, CD86) molecules. Man-LAM also promotes secretion of IL-10 by LPS-stimulated DCs and inhibits IL-12 production, thereby contributing to immune suppression (189, 200) . Both mannooligosaccharide caps and glycosylphosphatidylinositol anchor fatty acids play a critical role in inhibition of IL-12 production by Man-LAM (200) . Given that ManLAMs can activate the tyrosine phosphatase SHP-1, it is plausible that Man-LAMs exert their anti-inflammatory functions by dephosphorylating kinases such as the MAPKs that are involved in TNF-a and IL-12 production (89, 201) . Several studies suggest that apoptosis occurs in mycobacteria-infected macrophages. Man-LAM contributes to inhibition of apoptosis in Mtbinfected macrophages (202, 203) and may prevent apoptosis in infected macrophages by inhibiting the calcium influx associated with phagocytosis of Mtb by macrophages, thus leading to inhibition of the calciumdependent events required for apoptosis (203) . Ca 2þ participates in signal transduction and regulation of gene expression through CREB, which is phosphorylated following increases in intracellular Ca 2þ . c-AMP response element is present in the promoter region of the TNF-a gene and CREB also participates in the IFNg-dependent JAK/STAT signaling involved in apoptosis. Man-LAM inhibits CREB functions by inhibiting nuclear translocation of CREB. It has been proposed that Man-LAM affects TNF-a/IL-10 balance towards increased IL-10, which is believed to be an anti-apoptotic cytokine (47, 204) . Man-LAM may also inhibit the intrinsic pathway of apoptosis by inducing PI-3K/Aktdependent phosphorylation of Bad in Mtb-infected macrophages. Bad, a pro-apoptotic protein, is a member of the Bcl-2 family, which inhibits Bcl-XL (antiapoptotic protein) function by sequestering it as a heterodimer. Bad phosphorylation causes its dissociation from the heterodimer, thus leading to its sequestration in the cytosol in association with 14-3-3 (205) . A recent study using a murine infection model has shown that Man-LAM is able to promote extra-cellular release of soluble TNF-a receptor. Moreover, serum samples from Mtb-infected patients were reported to have high concentrations of the soluble TNF-a receptor, indicating the possibility that Man-LAM also interferes with the extrinsic pathway for apoptosis by neutralizing and regulating the activity of TNF-a (206) .
OTHER PATHWAYS THAT ARE ALTERED DURING MYCOBACTERIAL INFECTION
Actin is an important component of the cellular cytoskeletal network in eukaryotic cells and plays roles in several cellular processes, such as cell migration, membrane ruffling, phagocytosis, organ motility, formation of stress fibers and cellular adherence to the extracellular matrix (207) . Pathogenic species of mycobacteria have been shown to interfere with the actin filament network of host cells (208) .
Mycobacterial infections have been shown to induce disruption of actin filaments, leading to delayed acquisition of phagosomal maturation markers, which suggests that alterations in the endocytic transportation system during infection involve dysfunction of actin filaments (209) . A study using fluorescent microscopy approach reported inhibition of actin assembly on phagosomes in macrophages infected with live, but not killed Mtb. The same study also showed that actin assembles on phagosomes in macrophages infected with MS, suggesting that pathogenic mycobacteria actively inhibit actin assembly to avoid killing by macrophages (210) . Several lipids, including arachidonic acid, phosphatidylinositide (4, 5)-bisphosphate (PI(4, 5)P2), and ceramide have been shown to activate and restore actin assembly on phagosomes in macrophages infected with pathogenic mycobacteria, resulting in phagosomal maturation and enhanced killing of pathogens (211) . Mycobacterium marinum, the agent of tuberculosis-like disease in frogs, fish and occasionally in humans, has been reported to interfere with the host cell actin filament network (212) . Intraphagosomal M. marinum induces formation of actin fibers, enabling the pathogen to escape from the phagosomes into the cytosol of infected cells and further into neighboring cells (212) . Comparisons of gene expression during infection of monocytes with pathogenic and non-pathogenic mycobacteria have also revealed differences in expression of genes involved in actin polymerization (213) suggesting that pathogenic and non-pathogenic mycobacteria regulate actin polymerization differentially. In monocytes, expression of mycobacterial protein tyrosine phosphatase A induces increased polymerization of Factin at the surface of phagosomes containing opsonized zymosan. Recombinant mycobacterial protein tyrosine phosphatase A also promotes the process of actin polymerization on the surfaces of isolated phagosomes. These observations suggest that mycobacteria-derived enzyme/molecules influence actin polymerization during infection (214) . Pathogenic mycobacteria have also developed several mechanisms for avoiding killing by the ROI and RNI produced in response to infection as well as for avoiding the acidic pH inside host macrophages (215) .
CONCLUSIONS
Macrophages, the most important cells of the innate component of the immune system, are specialized for uptake and killing of invading pathogens and for initiating activation of specific immunity to the pathogens encountered by presenting antigenic peptides to the T cells. Despite their inherent phagocytic nature, macrophages fail to kill and eliminate Mtb, a pathogen equipped with diverse strategies for immune evasion, leading to the development of tuberculosis. Interactions of mycobacteria with host cells are complex and determine many aspects of pathogenesis. Pathogenic mycobacteria appear to have evolved from saprophytic mycobacterial species found in soil through acquisition of multiple evasion strategies that have enabled them to survive and replicate inside macrophages. The success of Mtb as a pathogen lies in its ability to infect macrophages and survive within them. Macrophage parasitization by Mtb requires adaptation and survival in the otherwise hostile environment by utilizing nutrients available within host. Mycobacteria may direct their entry into host cells through several surface receptors without significantly altering their intracellular fate. Signal transduction events occurring through these receptors control several processes that favor pathogen's survival within cells designed to kill them. Several factors of both host and pathogen origin, including cytokines, protein kinases, lipids and other components of signal transduction events determine the intracellular fate of mycobacteria. Significant progress has been made in understanding mycobacterial pathogenesis; however, more detailed investigations are needed to clarify the factors that are critical to regulation of survival of mycobacteria in their hosts and to identification of pathways and cellular targets that are suitable for designing new inhibitors of mycobacterial survival in their hosts. 
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